Esplenomegalia. DG. Daniela Gomez Levy. Updated 13 September Transcript. Funciones de bazo. Aumento de las necesidades funcionales. falciforme e persistência da esplenomegalia (Doença SC, S- β-talassemia) podem ram que 1/3 desses pacientes desenvolve hiperesplenismo. Em estudo . Download Citation on ResearchGate | On Mar 31, , Henry Mauricio Rodríguez and others published Esplenomegalia criptogénica con hiperesplenismo.
|Published (Last):||13 December 2016|
|PDF File Size:||13.24 Mb|
|ePub File Size:||14.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
CiteScore measures average citations received per document published.
Esplenomegalia gigante y linfoma no Hodgkin
Sinistral, or left-sided, portal hypertension SPH is a rare entity, with multiple potential causes. Access to the full text of this article requires a subscription. Access to the PDF text. This item has received. Subscriber If you already have your login data, please click here.
As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
You can move this window by clicking on the headline. Continuing navigation will be considered as acceptance of this use. Previous article Next article.
February Pages If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Specific treatment is seldom performed or needed.
Outline Masquer le plan. Causes of SPH, clinical manifestations and outcomes were registered. Se continuar a navegar, consideramos que aceita o seu uso.
Patients with clinical, radiological or laboratory alterations suggestive of cirrhosis were excluded. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted. The main aim of the present study is to summarize the clinical features of patients with SPH. Acute and chronic pancreatitis are the major causes of SHP.
You can change the settings or obtain more information by clicking here. Personal information regarding our website’s visitors, including their identity, is confidential. Gastrointestinal hiperespleniamo bleeding and hypersplenism are its’ major clinical manifestations.
Show more Show less. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Patients without liver enzymes elevation had a higher probability of gastrointestinal bleeding The Journal publishes scientific articles esplenomgealia all areas within its specialty: Potential factors associated with gastrointestinal bleeding were analyzed. In the study period a total of 22 patients male – 17; mean age – Gastrointestinal bleeding is the most important clinical manifestation and patients without liver enzyme elevation seem more prone to bleed.
SRJ is a prestige metric based on the idea that not all citations are the same. This was a retrospective analysis of consecutive patients with present or previous diagnosis of SHP, observed in a Gastroenterology Department, in a period of 2 years. Print Send to a friend Export reference Mendeley Statistics.
Esplenomegalia en el niño – EM|consulte
Contact Help Who are we? Si continua navegando, consideramos que acepta su uso. Access to the text HTML. Are you a health professional able to prescribe or dispense drugs?
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
There were no cases of variceal rebleeding and two patients died. Subscribe to our Newsletter. Top of the page – Article Outline. From Monday to Friday from 9 a. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Esplenomegalia e inmunodeficiencia primitiva Inmunodeficiencia primitiva con hipogammaglobulinemia.